ECOR
Price
$7.54
Change
+$0.95 (+14.42%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
37.04M
QDEL
Price
$27.76
Change
+$2.03 (+7.89%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
3.14B
6 days until earnings call
Ad is loading...

ECOR vs QDEL

Header iconECOR vs QDEL Comparison
Open Charts ECOR vs QDELBanner chart's image
electroCore
Price$7.54
Change+$0.95 (+14.42%)
Volume$800
Capitalization37.04M
QuidelOrtho
Price$27.76
Change+$2.03 (+7.89%)
Volume$61.86K
Capitalization3.14B
ECOR vs QDEL Comparison Chart
Loading...
ECOR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QDEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ECOR vs. QDEL commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ECOR is a Buy and QDEL is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (ECOR: $6.57 vs. QDEL: $25.73)
Brand notoriety: ECOR and QDEL are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ECOR: 71% vs. QDEL: 153%
Market capitalization -- ECOR: $37.04M vs. QDEL: $3.14B
ECOR [@Medical Specialties] is valued at $37.04M. QDEL’s [@Medical Specialties] market capitalization is $3.14B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ECOR’s FA Score shows that 0 FA rating(s) are green whileQDEL’s FA Score has 1 green FA rating(s).

  • ECOR’s FA Score: 0 green, 5 red.
  • QDEL’s FA Score: 1 green, 4 red.
According to our system of comparison, both ECOR and QDEL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ECOR’s TA Score shows that 4 TA indicator(s) are bullish while QDEL’s TA Score has 4 bullish TA indicator(s).

  • ECOR’s TA Score: 4 bullish, 3 bearish.
  • QDEL’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ECOR is a better buy in the short-term than QDEL.

Price Growth

ECOR (@Medical Specialties) experienced а +9.87% price change this week, while QDEL (@Medical Specialties) price change was +1.82% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +4.26%. For the same industry, the average monthly price growth was -6.64%, and the average quarterly price growth was -2.53%.

Reported Earning Dates

ECOR is expected to report earnings on Mar 12, 2025.

QDEL is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Medical Specialties (+4.26% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
QDEL($3.14B) has a higher market cap than ECOR($37M). QDEL YTD gains are higher at: -42.245 vs. ECOR (-59.469). QDEL has higher annual earnings (EBITDA): 607M vs. ECOR (-18.24M). QDEL has more cash in the bank: 167M vs. ECOR (10.3M). ECOR has less debt than QDEL: ECOR (626K) vs QDEL (2.61B). QDEL has higher revenues than ECOR: QDEL (3B) vs ECOR (16M).
ECORQDELECOR / QDEL
Capitalization37M3.14B1%
EBITDA-18.24M607M-3%
Gain YTD-59.469-42.245141%
P/E RatioN/A9.76-
Revenue16M3B1%
Total Cash10.3M167M6%
Total Debt626K2.61B0%
FUNDAMENTALS RATINGS
ECOR vs QDEL: Fundamental Ratings
ECOR
QDEL
OUTLOOK RATING
1..100
1259
VALUATION
overvalued / fair valued / undervalued
1..100
45
Fair valued
56
Fair valued
PROFIT vs RISK RATING
1..100
97100
SMR RATING
1..100
9694
PRICE GROWTH RATING
1..100
6593
P/E GROWTH RATING
1..100
10012
SEASONALITY SCORE
1..100
n/a75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ECOR's Valuation (45) in the Medical Specialties industry is in the same range as QDEL (56). This means that ECOR’s stock grew similarly to QDEL’s over the last 12 months.

ECOR's Profit vs Risk Rating (97) in the Medical Specialties industry is in the same range as QDEL (100). This means that ECOR’s stock grew similarly to QDEL’s over the last 12 months.

QDEL's SMR Rating (94) in the Medical Specialties industry is in the same range as ECOR (96). This means that QDEL’s stock grew similarly to ECOR’s over the last 12 months.

ECOR's Price Growth Rating (65) in the Medical Specialties industry is in the same range as QDEL (93). This means that ECOR’s stock grew similarly to QDEL’s over the last 12 months.

QDEL's P/E Growth Rating (12) in the Medical Specialties industry is significantly better than the same rating for ECOR (100). This means that QDEL’s stock grew significantly faster than ECOR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ECORQDEL
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
76%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
68%
Momentum
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
78%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 11 days ago
69%
Declines
ODDS (%)
Bearish Trend 21 days ago
86%
Bearish Trend 3 days ago
79%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
77%
View a ticker or compare two or three
Ad is loading...
ECOR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QDEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PAR57.411.57
+2.81%
PAR Technology Corp
DOOO33.480.60
+1.82%
BRP
LGL6.550.05
+0.77%
LGL Group (The)
ARL12.480.03
+0.24%
American Realty Investors
STZ187.280.28
+0.15%
Constellation Brands

ECOR and

Correlation & Price change

A.I.dvisor tells us that ECOR and QDEL have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ECOR and QDEL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ECOR
1D Price
Change %
ECOR100%
+0.23%
QDEL - ECOR
30%
Poorly correlated
+5.19%
CORBF - ECOR
27%
Poorly correlated
N/A
GKOS - ECOR
27%
Poorly correlated
+3.21%
EXAS - ECOR
24%
Poorly correlated
-0.14%
INMD - ECOR
24%
Poorly correlated
-0.32%
More